By: Allison Terbush, Coscoy Lab Photo credit: Katherine Chen, Vance Lab It is estimated that up to one-third of the global population is infected with Mycobacterium tuberculosis, the infectious agent of tuberculosis disease. Tuberculosis itself, and in combination with other complicating circumstances such as HIV infection, is among the leading causes of death world-wide. Despite this

Aduro CEO Stephen Isaacs talk about IVRI and the Alliance for Global Health and Science during the opening bell for Nasdaq Market in New York City on March 28. Video can be found here.

This coalition is gearing up for the fight against infectious disease. Here’s what they’re doing: “Over the next 5 years, the CEPI plans to bankroll the development of vaccines against three viral threats—Middle East respiratory syndrome (MERS)-coronavirus, Lassa, and Nipah—so that small outbreaks never get a chance to become raging epidemics. Formed last year without serious funding,

UC Berkeley’s Immunotherapeutics and Vaccine Research Institute is changing the way we think about cancer and infectious diseases. It turns out that these two have a lot in common, and IVRI is utilizing discoveries in both fields to create strides in treatment. The current issue of the journal Science Immunology features Russell Vance, Daniel Portnoy, Michael Eichberg, and David

2016 MHIRT Fellows, Frida Ceja’s and Alexis Toruño’s, international summer research experiences profiled in Dominican University of California newsletter. “Last spring, Alexis [Toruño], along with biology major Frida Ceja ‘17, received National Institute for Health (NIH) Global Health Disparities Research Fellowships through UC Berkeley’s Center for Emerging and Neglected Diseases. The fellowships were funded by

The Annual Bay Area Symposium on Viruses was held on Friday, May 27th in the Li Ka Shing Auditorium on UC Berkeley’s main campus. This was the 6th year of the symposium, which brought together approximately 300 members of the Bay Area virology community for a series of scientific talks by faculty, industry representatives, post-docs, and

By Robert Sanders, Media Relations, UC Berkeley News UC Berkeley cancer immunologists are teaming up with colleagues working on infectious disease to create a new Immunotherapeutics and Vaccine Research Initiative, fueled by $7.5 million in funding from Aduro Biotech Inc., a Berkeley company that develops immunotherapies for cancer and other diseases. Aduro’s three years of

The University of California, Berkeley is officially launching the Alliance for Global Health and Science (the Alliance), thanks to a $1 million gift from Berkeley alumnus and Chairman, President and Chief Executive Officer of Aduro Biotech Stephen T. Isaacs. Recently, events such as the spread of Zika virus to Latin America and the 2014 Ebola

Henry H. “Sam” Wheeler Jr., the founding donor and namesake for the Center for Emerging and Infectious Diseases, died this month at his home in Southern California. Sam was a highly engaged and interested supporter of CEND, and he will be sorely missed. Sam Wheeler was born in California in 1927. Ten years later, his

“Every summer, students from across UC Berkeley eagerly plan and prepare for overseas adventures. Many have ambitions to explore the world, learn new things, create lifelong memories, and seek adventure. And for some, high on the to-do checklist is to improve the lives of those less fortunate, in resource-poor communities far, far away from the sprawling green lawns and clear blue skies of